Moonis M, Swearer JM, Dayaw MP, St George-Hyslop P, Rogaeva E, Kawarai T, Pollen DA. Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline. Neurology. 2005 Jul 26;65(2):323-5. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. This, and other important work in a similar vein, suggests that "Alzheimerization" of brain occurs at least a decade prior to occurrence of symptoms. If clinically practical early markers for this process can be discovered, it would enable the identification of individuals who could be targeted for prevention strategies. Furthermore, if the changes can be measured longitudinally, mitigation of marker progression over time may serve as a practical surrogate marker for preventive intervention trials.

    View all comments by John Breitner

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Mutations

  1. PSEN1 C410Y

News

  1. St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD?
  2. London: What, No Argument? Speakers Agree on Trials for Familial AD

Research Timeline Event

  1. CSF Aβ, CSF Aβ/tau ratio predicts decline in cognitively normal elderly and FAD mutation carriers